重度退行性上睑下垂:Müller肌结膜切除术与外路提上睑肌缩短术疗效比较
该回顾性比较病例系列纳入2012至2019年接受上睑下垂修复术且资料完整的患者,比较Müller肌结膜切除术(MMCR)与外路提上睑肌缩短术(ELR)在重度退行性上睑下垂中的效果。重度下垂定义为MRD1≤0 mm,手术失败定义为患者或医生对术后睑高不满意或术后MRD1<2 mm。
核心结论
- MMCR是治疗重度上睑下垂的有效方法,可能优于ELR。
- 对去氧肾上腺素反应良好的患者,无论就诊时MRD1如何,MMCR可能提供高效且疗效显著的手术选择。
研究设计与样本
- 回顾性、干预性、比较性病例系列,回顾2012至2019年接受上睑下垂修复术的患者。
- 纳入标准为接受MMCR或ELR、术前眼睑测量记录完整且术后结局有记录的患者。
- 共231例患者(372眼睑)符合研究标准,其中142眼睑为重度上睑下垂。
- 重度上睑下垂定义为MRD1为0或更差。
- 主要结局指标为手术失败,定义为患者或医生报告对术后睑高不满意或术后MRD1小于2 mm。
主要发现
- 同期行眼睑成形术未影响任何组别的上睑下垂修复结局。
关键数值与推荐
- 重度上睑下垂定义为MRD1为0或更差。
- 手术失败定义为患者或医生报告对术后睑高不满意或术后MRD1小于2 mm。
- 重度上睑下垂中MMCR成功率97.2%,ELR成功率77.4%。
- 轻度/中度上睑下垂中MMCR成功率90.9%,ELR成功率85%。
临床怎么用
- 对重度退行性上睑下垂,MMCR可作为有效术式,且可能优于ELR。
- 对去氧肾上腺素反应良好的患者,可考虑MMCR而不必拘泥于就诊时MRD1。
- 同期行眼睑成形术不影响上睑下垂修复结局。
局限性
- 本研究为回顾性、干预性、比较性病例系列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare outcomes between Müller muscle conjunctival resection (MMCR) ptosis repair and external levator resection (ELR) in patients with severe involutional blepharoptosis. DESIGN: Retrospective, interventional, comparative case series. METHODS: A retrospective review was performed of patients who underwent ptosis repair between 2012 and 2019. Inclusion criteria were patients who underwent MMCR or ELR ptosis repair, patients with complete documentation of preoperative eyelid measurements, and patients with documentation of postoperative outcome. The main outcome measure was surgical failure, defined as patient-reported or physician-reported dissatisfaction with postoperative eyelid height or postoperative upper margin reflex distance (MRD1) of less than 2 mm. Severe ptosis was described as an MRD1 of 0 or worse. Outcome analysis was also performed after stratification for concomitant blepharoplasty performed at the time of ptosis repair. RESULTS: A total of 231 patients (372 eyelids) met the study criteria, of which 142 eyelids had severe ptosis. Comparing outcomes of MMCR vs ELR in patients with severe ptosis, there was a statistically significant higher rate of success after MMCR (P = .0143). The rate of ptosis repair success in eyelids that underwent MMCR was 97.2% and 90.9% in patients with severe ptosis and mild/moderate ptosis, respectively (P = .42). In eyelids that underwent ELR, the rate of ptosis repair success was 77.4% and 85% in eyelids with severe ptosis and mild/moderate ptosis, respectively (P = .15). Concomitant blepharoplasty did not affect ptosis repair outcomes in any group. CONCLUSIONS: MMCR ptosis repair is an effective approach in treating patients with severe ptosis, and it may offer superior outcomes to ELR. In patients with good responses to phenylephrine, MMCR may offer an efficient and highly efficacious surgery regardless of presenting MRD1.
引用
- Sweeney AR, Dermarkarian CR, Williams KJ, et al. Outcomes After Müller Muscle Conjunctival Resection Versus External Levator Advancement in Severe Involutional Blepharoptosis. Am J Ophthalmol. 2020. PMID: 32387434. doi:10.1016/j.ajo.2020.04.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。